Assertio Holdings | DEPO - Gross Profit On Sales

Stock Price
22.51
Daily Change
0.14 0.62%
Monthly
24.91%
Yearly
146.00%
Q2 Forecast
18.09

Assertio Holdings reported $22.24M in Gross Profit on Sales for its fiscal quarter ending in June of 2024.





Gross Profit On Sales Change Date
ANI Pharmaceuticals USD 124.18M 12.39M Dec/2025
Assertio Holdings USD 22.24M 970K Jun/2024
Aurora Cannabis CAD 46.62M 14.33M Dec/2025
Cara Therapeutics USD 2.57M 1.11M Mar/2025
Daiichi Sankyo JPY 439.83B 95.05B Dec/2025
Ironwood Pharmaceuticals USD 85.24M 44.1M Jun/2025
J&J USD 17.24B 642M Mar/2026
Knight Therapeutics CAD 64.72M 8.91M Dec/2025
Merck USD 10.85B 2.57B Dec/2025
Nektar Therapeutics USD 21.81M 8.06M Dec/2025
Omeros USD -33.16M 18.52M Jun/2024
Pfizer USD 11.04B 1.24B Mar/2026
Teva Pharmaceutical Industries USD 2.11B 547M Mar/2026